Fefasdin 60 khapharco treatment of allergic rhinitis, indefininant urticaria (10 blisters x 10 tablets)
Dosage form Film bag tablets
Specifications Box of 10 blisters x 10 tablets
Ingredient Fexofenadin hydrochlorid
Indication Rhinitis, allergic rhinitis, itching, stuffy nose
Ingredient
Thành phần cho 1 viên
| Composition information | Content |
| Fexofenadin hydrochlorid | 60mg |
Uses
Indications
Fefasdin 60 drug is indicated in the following cases:
Dynamic pharmacokinetics
absorption: Fexofenadin hydrochloride absorbs well when used orally and starts to work after drinking 60 minutes. The peak concentration in the blood is achieved after 2-3 hours. Fat -rich foods reduce the peak concentration in plasma by about 17% and extend the time to reach the peak concentration of the drug (until about 4 hours). The antihistamine effect lasts more than 12 hours.
Distribution: The ratio of linking to the drug's blood protein is 60-70%, mainly with albumin and alpha-acid glycoprotein. It is unclear whether the drug is through the placenta or excretion in breast milk, but when using terfenadin has detected fexofenadin is the metabolic substance of terfenadin in breast milk. Fexofenadin does not pass the blood - brain barrier.
Metabolism: Fexofenadin is very little metabolized (about 5%, mainly in the intestinal mucosa. Only about 0.5-1.5% are metabolized in the liver thanks to the cytochrom paso enzyme into active substance). About 3.5% of fexofenadin dose is metabolized through phase II (not related to the cytochrom P450 enzyme system) into methyl ester derivatives. This metabolite is only seen in the stool, so there may be the participation of intestinal bacteria into this metabolism.
Elimination: Half of the excretion of Fexofenadin is about 14.4 hours, longer (31-72%) in kidney failure people. The drug excreted mainly in feces (approximately 80%) and urine (11-12%) in constant form.
Pharmacokinetics in people with renal failure:
CICR 41-80 ml/minute: The peak concentration is 87%high, half-life eliminated longer than 50%.
CLCR 11-40 ml/minute: peak concentration is more than 111%, half-life eliminated longer than 72%.
CLCR
Ineffective blood decomposition removal.
Before taking Fefasdin 60 khapharco treatment of allergic rhinitis, indefininant urticaria (10 blisters x 10 tablets)
How to use
Take oral use.
Dosage
The usual dose for adults and children over 12 years: 1 capsule 2 times/day.
Elderly and kidney failure:
Children aged 12 years and older and adults with kidney failure, the elderly: Start taking a dose of 1 tablet 1 time/day, adjust the dose according to the kidney function.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do
do when overdose? However, drowsiness, dizziness, dry mouth have been reported.
Handling: Using conventional measures to remove the drug that has not been absorbed in the gastrointestinal tract. Support support and symptomatic treatment. Hemolysis is negligible in blood concentration (1.7%). There is no specific antidote.
What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.
Side Effects
When using Fefasdin 60 you may experience unwanted effects (ADR).
Common, ADR> 1/100
Uncommon, 1/1000 Rare, ADR Immune: urticaria, itching, angioedema, chest tightness, shortness of breath, redness, anaphylaxis. Instructions on how to handle ADR The unwanted effects of the drug are usually mild, only 2.2% of patients have to stop the drug due to the unwanted effects of the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindications:
Fefasdin 60 drug contraindicated in the following cases:
Be cautious when using
Although the drug has no heart toxicity like Terfenadin, it still needs to be cautious for people who have a cardiovascular risk or have a long QT from before.
Do not use any other antihistamine drugs when using fexofenadin hydrochloride.
Caution and adjustment of appropriate dosage when taking drugs for people with impaired renal function, the elderly (over 65 years old).
Safety and effectiveness of drugs in children under 6 years old have not been determined.
Need to stop Fexofenadin at least 24 - 48 hours before conducting subcutaneous antigen tests.
The drug contains lactose excipients, not suitable for patients with lactase enzyme deficiency, malabsorption syndrome due to blood galactose.
The ability to drive and operate machinery
Although Fexofenadin hydrochloride is less likely to cause drowsiness, it still needs to be cautious when driving or controlling machinery requires alertness.
Pregnancy
There is no complete research document on pregnant women, so only Fexofenadin for pregnant women when the benefit of the mother is superior to the risk for the fetus.
The period of breastfeeding
It is not clear whether the drug is excreted through breast milk, so be careful when using fexofenadin for breastfeeding women.
Drug interaction
erythromycin and ketoconazole increases concentration and area under the concentration curve - time of fexofenadin hydrochloride in the blood.
Antacomicius containing aluminum, magnesi if used simultaneously with fexofenadin hydrochloride will reduce the absorption of the drug, so they must use these drugs about 2 hours apart.
Due to the absence of studies on the correlation of the drug, not mixing this drug with other drugs.
Storage
less than 30 ° C. Dry place, avoid light.
Other drugs
- CLEXANE 80MG/0.8ML SYRINGES
- COSMOFER 50MG/ML SOLUTION FOR INJECTION AND FOR INFUSION
- IBUCALM 200MG TABLETS
- MICTONORM 15 MG COATED TABLETS
- OXYNORM 10MG CAPSULES
- WINTOGENO CREAM
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions